SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-13-339732
Filing Date
2013-08-19
Accepted
2013-08-19 17:13:00
Documents
1
Group Members
DANIEL S. OCHOCH-ZIFF CAPITAL MANAGEMENT GROUP LLCOCH-ZIFF HOLDING CORP

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G d585846dsc13g.htm SC 13G 118130
  Complete submission text file 0001193125-13-339732.txt   119818
Mailing Address 249 E. GRAND AVE. SOUTH SAN FRANCISCO CA 94080
Business Address 249 E. GRAND AVE. SOUTH SAN FRANCISCO CA 94080 650-266-0000
ONYX PHARMACEUTICALS INC (Subject) CIK: 0001012140 (see all company filings)

IRS No.: 943154463 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-45955 | Film No.: 131048946
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 9 WEST 57TH STREET, 39TH FLOOR NEW YORK NY 10019
Business Address 9 WEST 57TH STREET, 39TH FLOOR NEW YORK NY 10019 2127900165
OZ MANAGEMENT LP (Filed by) CIK: 0001054587 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G